Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report

OBJECTIVE: Major depressive disorder (MDD) is projected to be a leading cause of disability globally by 2030. Only a minority of patients remit with antidepressants. If assay of polymorphisms influencing central nervous system (CNS) bioavailability could guide prescribers to more effectively dose pa...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Psychopharmacol Neurosci
Hoofdauteur: Singh, Ajeet B.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Korean College of Neuropsychopharmacology 2015
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540033/
https://ncbi.nlm.nih.gov/pubmed/26243841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2015.13.2.150
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items